Abstract
Cardiovascular diseases (CVDs) remain a leading cause of mortality worldwide. Despiteinnovative treatments, both pharmacological and interventional, CVDs continue toprogress. This is largely due to the increased incidence of diseases such as diabetes andother well-established cardiovascular risk factors, as well as cumulative comorbidities andemerging risk factors.